4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-26-001961
Director sold 18,410 shares at an average $522.40 ($9,617,312)
- Director acquired 18,410 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taub Rebecca Director | 2026-01-09 | Option exercise 10b5-1 | +18,410 | $15.80 | $290,878 | 473,999 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −960 | $512.02 | $491,537 | 473,039 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −960 | $513.12 | $492,595 | 472,079 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −937 | $514.63 | $482,207 | 471,142 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −1,578 | $515.82 | $813,968 | 469,564 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −521 | $516.81 | $269,257 | 469,043 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −2,044 | $517.84 | $1,058,468 | 466,999 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −970 | $518.67 | $503,106 | 466,029 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −539 | $519.89 | $280,220 | 465,490 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −440 | $521.11 | $229,289 | 465,050 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −588 | $521.95 | $306,909 | 464,462 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −732 | $522.98 | $382,823 | 463,730 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −1,335 | $524.06 | $699,623 | 462,395 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −1,489 | $525.12 | $781,903 | 460,906 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −913 | $526.05 | $480,281 | 459,993 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −1,135 | $526.95 | $598,091 | 458,858 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −465 | $528.16 | $245,593 | 458,393 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −554 | $529.28 | $293,222 | 457,839 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −256 | $530.45 | $135,796 | 457,583 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −30 | $531.05 | $15,932 | 457,553 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −40 | $532.50 | $21,300 | 457,513 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −271 | $534.18 | $144,761 | 457,242 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −89 | $534.93 | $47,609 | 457,153 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −299 | $535.80 | $160,205 | 456,854 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −385 | $536.88 | $206,700 | 456,469 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −40 | $537.84 | $21,514 | 456,429 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −400 | $539.26 | $215,706 | 456,029 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −40 | $540.26 | $21,610 | 455,989 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −400 | $542.72 | $217,088 | 455,589 | D |
| Derivatives | |||||||
| Taub Rebecca Director | 2026-01-09 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,410 | 240 | D | ||
| Open-market sales · 18,410 sh · avg $522.40 · $9,617,312 | |||||||
Loading xslF345X05/wk-form4_1768340044.xml…